CSL CEO on Financial Results, Business Outlook

Feb. 12 (Bloomberg) -- Paul Perreault, chief executive officer of CSL Ltd., Australia's biggest pharmaceutical company, talks about its financial results and business outlook. CSL reported a 3.4 percent increase in first-half profit, helped by surging sales of an antidote for the blood-thinner warfarin. Perreault speaks from Melbourne with Angie Lau on Bloomberg Television's "First Up." (Source: Bloomberg)
How Pollution Documentary Spawned 2 Billionaires in China
12:45 - March 4 -- Two Chinese entrepreneurs became billionaires as their companies rose to records on the prospect of new pollution laws after a Chinese documentary similar to “An Inconvenient Truth” sparked interest in environmentalism. Bloomberg's Christine Hah reports on "Trending Business."
  • Japan High-School Graduates Are Seeing a Hot Job Market
  • Thailand Tops List of World's 15 Happiest Economies
  • It is Not All Fiscal Paradise for U.S. Virgin Islands